Literature DB >> 33753988

Multidisciplinary team consultation for resectable Gastric Cancer: A propensity score matching analysis.

Yonghe Chen1,2, Jun Xiang1,2, Dan Liu3, Jian Xiao4,2, Fei Xiong5,2, Kaikai Wei5,2, Aihong Liu1,2, Shi Chen1,2, Yaxi Zhu6,2, Xiaochun Meng5,2, Junsheng Peng1,2.   

Abstract

Purpose: Previous studies proposed that the multidisciplinary team (MDT) consultation could improve tumor staging accuracy and outcomes of patients with gastric malignancy. However, evidence-based reports remain limited. This study aimed to determine the effectiveness of MDT for tumor staging accuracy and outcomes of patients with resectable gastric cancer, and to explore the potential factors affecting its effectiveness.
Methods: This retrospective study enrolled 719 gastric cancer patients who underwent gastrectomy in our hospital. After propensity score matching, 378 patients were selected, including 189 in the non-MDT group and 189 in the MDT group. Data regarding baseline characteristics, staging, treatments, and survival were analyzed.
Results: The data showed that the staging accuracy in the MDT group and non-MDT group was comparable (53% vs 61% for T stage, 46.1% vs 35.3% for N stage, and 78.3% vs 78.7% for M stage). The MDT group had a higher proportion of preoperative chemotherapy (39.2% vs 28%, p=0.03) and laparoscopic surgery (82.5% vs 72%, p=0.02) than the non-MDT group. However, the achievement of R0 resection was similar in the two groups (93.7% vs 88.9%, p=0.73). There was no significant difference in the 1-year and 3-year overall survival rates between the two groups. Moreover, we observed poor patient compliance when the MDT recommended further examinations, radiotherapy, or chemotherapy before surgical interventions.
Conclusion: MDT consultation has limited effects on improving the staging accuracy and treatment outcomes including survival of patients with resectable gastric cancer. Poor patient compliance may be a factor affecting the effectiveness of MDT consultation. © The author(s).

Entities:  

Keywords:  gastric cancer; multidisciplinary team consultation; patient compliance; propensity score matching; survival

Year:  2021        PMID: 33753988      PMCID: PMC7974536          DOI: 10.7150/jca.53365

Source DB:  PubMed          Journal:  J Cancer        ISSN: 1837-9664            Impact factor:   4.207


  30 in total

1.  Multidisciplinary team working in cancer: what is the evidence?

Authors:  Cath Taylor; Alastair J Munro; Rob Glynne-Jones; Clive Griffith; Paul Trevatt; Michael Richards; Amanda J Ramirez
Journal:  BMJ       Date:  2010-03-23

2.  The multidisciplinary team meeting improves staging accuracy and treatment selection for gastro-esophageal cancer.

Authors:  A R Davies; D A C Deans; I Penman; J N Plevris; J Fletcher; L Wall; H Phillips; H Gilmour; D Patel; A de Beaux; S Paterson-Brown
Journal:  Dis Esophagus       Date:  2006       Impact factor: 3.429

Review 3.  Multidisciplinary teams in cancer care: are they effective in the UK?

Authors:  Anne Fleissig; Valerie Jenkins; Susan Catt; Lesley Fallowfield
Journal:  Lancet Oncol       Date:  2006-11       Impact factor: 41.316

4.  Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer.

Authors:  Hiroyuki Ono; Kenshi Yao; Mitsuhiro Fujishiro; Ichiro Oda; Satoshi Nimura; Naohisa Yahagi; Hiroyasu Iishi; Masashi Oka; Yoichi Ajioka; Masao Ichinose; Toshiyuki Matsui
Journal:  Dig Endosc       Date:  2015-10-04       Impact factor: 7.559

Review 5.  Multidisciplinary management of stage II-III gastric and gastro-oesophageal junction cancer.

Authors:  Anna D Wagner; Florian Lordick; Heike I Grabsch; Masanori Terashima; Mitsumi Terada; Takaki Yoshikawa; Narikazu Boku; Kozo Kataoka; Elizabeth C Smyth; Murielle Mauer; Karin Haustermans; Markus H Moehler
Journal:  Eur J Cancer       Date:  2019-11-20       Impact factor: 9.162

6.  Oxaliplatin plus S-1 or capecitabine as neoadjuvant or adjuvant chemotherapy for locally advanced gastric cancer with D2 lymphadenectomy: 5-year follow-up results of a phase II-III randomized trial.

Authors:  Kan Xue; Xiangji Ying; Zhaode Bu; Aiwen Wu; Zhongwu Li; Lei Tang; Lianhai Zhang; Yan Zhang; Ziyu Li; Jiafu Ji
Journal:  Chin J Cancer Res       Date:  2018-10       Impact factor: 5.087

Review 7.  Successful strategies in implementing a multidisciplinary team working in the care of patients with cancer: an overview and synthesis of the available literature.

Authors:  Tayana Soukup; Benjamin W Lamb; Sonal Arora; Ara Darzi; Nick Sevdalis; James Sa Green
Journal:  J Multidiscip Healthc       Date:  2018-01-19

Review 8.  The value of staging laparoscopy in gastric cancer.

Authors:  Nikolaos Machairas; Petros Charalampoudis; Ernesto P Molmenti; Stylianos Kykalos; Peter Tsaparas; Paraskevas Stamopoulos; Georgios C Sotiropoulos
Journal:  Ann Gastroenterol       Date:  2017-03-16

9.  Comparing PET/MRI with PET/CT for Pretreatment Staging of Gastric Cancer.

Authors:  Yi Liu; Dong Zheng; Jia-Jin Liu; Jian-Xin Cui; Hong-Qing Xi; Ke-Cheng Zhang; Xiao-Hui Huang; Bo Wei; Xin-Xin Wang; Bai-Xuan Xu; Ke Li; Yun-He Gao; Wen-Quan Liang; Jia-He Tian; Lin Chen
Journal:  Gastroenterol Res Pract       Date:  2019-02-03       Impact factor: 2.260

Review 10.  Role of staging laparoscopy for gastric cancer patients.

Authors:  Takeo Fukagawa
Journal:  Ann Gastroenterol Surg       Date:  2019-08-21
View more
  1 in total

1.  Adherence to Multidisciplinary Tumor Board Recommendations in Patients With Curable Esophageal and Gastric Cancers.

Authors:  Joel Jia Yi Soon; Yue Zhao; Nicholas Brian Shannon; Jeremy Tian Hui Tan
Journal:  J Gastrointest Cancer       Date:  2022-06-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.